Workflow
Humacyte(HUMA) - 2025 Q2 - Quarterly Results
HumacyteHumacyte(US:HUMA)2025-08-11 11:04
  • Total revenues of $301,000 for quarter, and $818,000 for first six months of 2025, from sales and collaborative research agreement - Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update Exhibit 99.1 "We were also gratified to see that our V007 trial data was one of only three presentations selected for special mention by the Society of Vascular Surgery in June, and that the Society chose to highlight the strength of the results in their own announcement," continued Dr. Nik ...